Catherine C. Turkel - 02 Sep 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Catherine C. Turkel/
Issuer symbol
LEXX
Transactions as of
02 Sep 2022
Net transactions value
$0
Form type
4
Filing time
06 Sep 2022, 12:53:24 UTC
Next filing
13 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +3,400 $0.000000 3,400 02 Sep 2022 Common Shares 3,400 $3.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.